These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17826618)

  • 1. Infections in chronic lung diseases.
    Parameswaran GI; Murphy TF
    Infect Dis Clin North Am; 2007 Sep; 21(3):673-95, viii. PubMed ID: 17826618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory Viral Infections in Chronic Lung Diseases.
    Britto CJ; Brady V; Lee S; Dela Cruz CS
    Clin Chest Med; 2017 Mar; 38(1):87-96. PubMed ID: 28159164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of methods for the isolation of nontuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation.
    Stephenson D; Perry A; Appleby MR; Lee D; Davison J; Johnston A; Jones AL; Nelson A; Bourke SJ; Thomas MF; De Soyza A; Lordan JL; Lumb J; Robb AE; Samuel JR; Walton KE; Perry JD
    BMC Pulm Med; 2019 Jan; 19(1):19. PubMed ID: 30665395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease.
    Valderrey AD; Pozuelo MJ; Jiménez PA; Maciá MD; Oliver A; Rotger R
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):20-7. PubMed ID: 20727465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung transplantation for non-cystic fibrosis bronchiectasis.
    Rademacher J; Ringshausen FC; Suhling H; Fuge J; Marsch G; Warnecke G; Haverich A; Welte T; Gottlieb J
    Respir Med; 2016 Jun; 115():60-5. PubMed ID: 27215505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The microbiome and emerging pathogens in cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Green H; Jones AM
    Semin Respir Crit Care Med; 2015 Apr; 36(2):225-35. PubMed ID: 25826590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lung microbiome in health and disease.
    Moffatt MF; Cookson WO
    Clin Med (Lond); 2017 Dec; 17(6):525-529. PubMed ID: 29196353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viruses exacerbating chronic pulmonary disease: the role of immune modulation.
    Singanayagam A; Joshi PV; Mallia P; Johnston SL
    BMC Med; 2012 Mar; 10():27. PubMed ID: 22420941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota: A Missing Link in The Pathogenesis of Chronic Lung Inflammatory Diseases.
    Magryś A
    Pol J Microbiol; 2021 Mar; 70(1):25-32. PubMed ID: 33815524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic obstructive pulmonary disease and bronchiectasis.
    Novosad SA; Barker AF
    Curr Opin Pulm Med; 2013 Mar; 19(2):133-9. PubMed ID: 23287285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease.
    Möller LV; Timens W; van der Bij W; Kooi K; de Wever B; Dankert J; van Alphen L
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):950-6. PubMed ID: 9517616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Pneumococcal Vaccination in Chronic Lung Diseases.
    Mahashur AA; Mullerpattan JB
    J Assoc Physicians India; 2015 Apr; 63(4 Suppl):31-3. PubMed ID: 26562962
    [No Abstract]   [Full Text] [Related]  

  • 13. [The lung microbiome in 2015: a window on chronic lung diseases].
    Andréjak C; Delhaes L
    Med Sci (Paris); 2015 Nov; 31(11):971-8. PubMed ID: 26576604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide is present in immune complexes isolated from sputum in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G; Shand GH; Fomsgaard A; Høiby N
    APMIS; 1992 Feb; 100(2):175-80. PubMed ID: 1554493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive ventilation in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis.
    Wedzicha JA; Muir JF
    Eur Respir J; 2002 Sep; 20(3):777-84. PubMed ID: 12358358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled tobramycin: not just for cystic fibrosis anymore?
    Lobue PA
    Chest; 2005 Apr; 127(4):1098-101. PubMed ID: 15821180
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhalation of macrolides: a novel approach to treatment of pulmonary infections.
    Siekmeier R; Hofmann T; Scheuch G
    Adv Exp Med Biol; 2015; 839():13-24. PubMed ID: 25252902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteria-driven peribronchial lymphoid neogenesis in bronchiectasis and cystic fibrosis.
    Frija-Masson J; Martin C; Regard L; Lothe MN; Touqui L; Durand A; Lucas B; Damotte D; Alifano M; Fajac I; Burgel PR
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28446556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rehabilitation in patients with chronic respiratory disease other than chronic obstructive pulmonary disease: exercise and physical activity interventions in cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Burtin C; Hebestreit H
    Respiration; 2015; 89(3):181-9. PubMed ID: 25676797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic mechanisms of chronic Pseudomonas aeruginosa infections in cystic fibrosis patients.
    Høiby N; Döring G; Schiøtz PO
    Antibiot Chemother (1971); 1987; 39():60-76. PubMed ID: 3118792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.